Inflammatory marker per SD increase | Breast cancer survivors | Non-exposed participants | P for interaction†|
---|---|---|---|
Mean difference* (95% CI) | Mean difference* (95% CI) | ||
Model I | |||
 Log GLR | −0.24 (−0.40 to −0.08) | −0.04 (−0.09 to 0.00) | 0.061 |
 Log PLR | −0.13 (−0.29 to 0.03) | 0.05 (0.01 to 0.10) | 0.003 |
 Log SII | −0.22 (−0.38 to −0.07) | −0.03 (−0.08 to 0.01) | 0.053 |
Model II | |||
 Log GLR | −0.23 (−0.39 to −0.08) | −0.02 (−0.07 to 0.02) | 0.038 |
 Log PLR | −0.18 (−0.33 to −0.02) | 0.03 (−0.01 to 0.08) | 0.003 |
 Log SII | −0.23 (−0.38 to −0.07) | −0.01 (−0.06 to 0.03) | 0.033 |